Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
18
datasets available to search
ShareScore release 0.9.0
Dataset results
18 results for “RESPIRATORY MEDICINE”
Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey
<p><b>Background:</b> The burden of the COVID-19 pandemic in Peru has led to people seeking alternative treatments as preventives and treatment options such as medicinal plants. This study aimed to assess factors associated with the use of medicinal plants as preventive or treatment of respiratory symptom related to COVID-19 during the pandemic in Cusco, Peru.<b> </b></p> <p><b>Method: </b>A web-based cross-sectional study was conducted on general public (20- to 70-year-old) from August 31 to September 20, 2020. Data were collected using a structured questionnaire via Google Forms, it consisted of an 11-item questionnaire that was developed and validated by expert judgment using Aiken's V (Aiken's V > 0.9). Both descriptive statistics and bivariate followed by multivariable logistic regression analyses were conducted to assess factors associated with the use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic. Prevalence ratios (PR) with 95% Confidence Interval (CI), and a P-value of 0.05 was used to determine statistical significance.</p> <p><b>Results: </b>A total of 1,747 respondents participated in the study, 80.2% reported that they used medicinal plants as preventives, while 71% reported that they used them to treat respiratory symptoms. At least, 24% of respondents used medicinal plants when presenting with two or more respiratory symptoms, while at least 11% used plants for malaise. For treatment or prevention, the multivariate analysis showed that most respondents used eucalyptus (p < 0.001 for both), ginger (p < 0.022 for both), spiked pepper (p < 0.003 for both), garlic (p = 0.023 for prevention), and chamomile (p = 0.011 for treatment). The respondents with COVID-19 (p < 0.001), at older ages (p = 0.046), and with a family member or friend who had COVID-19 (p < 0.001) used more plants for prevention. However, the respondents with technical or higher education used less plants for treatment (p < 0.001).</p> <p><b>Conclusion: </b>There was a significant use of medicinal plants for both prevention and treatment, which was associated with several population characteristics and whether respondents had COVID-19.</p>
Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19
ClinicalTrials.gov study NCT04653727. IPD Sharing: NO. Countries: 1. Publications: 1.
Study KBP-2020-CPHG Documenting New Cases of Primary Lung Cancer (PLC) Diagnosed in Respiratory Medicine Departments and Lung Cancer Units at General Hospitals From January 1st to December 31st 2020
ClinicalTrials.gov study NCT04402099. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey
Open the record for dataset details and reuse information.
A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection
ClinicalTrials.gov study NCT06079320. IPD Sharing: YES. Countries: 4. Publications: 0.
Evaluation of Respiratory Heast Loss as a Physiologic Patient Monitor for Acute Care Medicine
ClinicalTrials.gov study NCT01808963. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Antibacterial medicine use in the management of children under five years with symptoms of Acute respiratory tract infections in Northern Uganda
Open the record for dataset details and reuse information.
Precision Medicine in Anesthesia: Genetic Component in Opioid-induced Respiratory Depression
ClinicalTrials.gov study NCT03441282. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma)
ClinicalTrials.gov study NCT06373692. IPD Sharing: NO. Countries: 1. Publications: 0.
Respiratory Disease Cohort Studies of Chinese Medicine for COPD(RESEARCH-COPD)
ClinicalTrials.gov study NCT06577701. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Onco-Respirology Epidemiology Based on Real-world Big Data in Respiratory Medicine
ClinicalTrials.gov study NCT06670560. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Chinese Herbal Medicine in the Treatment of Upper Respiratory Tract Infections (URTIs)
ClinicalTrials.gov study NCT00887172. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study for Developing Artificial Intelligence(AI)-Based Clustering Model for Personalized Medicine in Acute Respiratory Failure
ClinicalTrials.gov study NCT06479421. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Respiratory Disease Cohort Studies of Chinese Medicine for Pulmonary Nodule
ClinicalTrials.gov study NCT06673121. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigation on the Epidemic Prevention Effect of Using Chinese Medicine During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak.
ClinicalTrials.gov study NCT05236309. IPD Sharing: Not stated. Countries: 1. Publications: 0.
REspiratory diSEAse cohoRt Studies of CHinese Medicine for ILD (RESEARCH-ILD)
ClinicalTrials.gov study NCT06577753. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine
ClinicalTrials.gov study NCT07274631. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Pneumonia (RESEARCH-Pneumonia)
ClinicalTrials.gov study NCT06220019. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.